Posted by Tye on April 2, 2002, at 20:20:07
In reply to Re: Kramer: reason the MAOI patch was rejected?, posted by Dr. Kramer on April 2, 2002, at 12:03:54
> Yeah. Unfortunately, it didn't work all that well. A Phase III clinical trial completed a while ago showed no signifigant difference from placebo.
Dear Dr. Kramer,
Actually the rate of response of the subjects enrolled in the selegiline patch study was approximately 75%. This was amongst a population that was for the most part treatment resistant with HAM-D scores averaging around 30. Unforunately, political agendas impair excellent medications from reaching the United States patient population, as I am sure your aware.
Tye
poster:Tye
thread:101404
URL: http://www.dr-bob.org/babble/20020402/msgs/101562.html